/

Pulmovant

Develops inhaled therapies for patients with pulmonary diseases.

BiotechnologyPharmaceuticals pulmovant.com ↗

Company facts

Founded: 2023
Employees: 30
Headquarters: United States
Type: Private
Funding: Corporate Round · $14M · 2024